The Dutch-Belgian Randomized Lung Cancer Screening Trial, known as the NELSON trial (de Koning et al), published Jan. 29 in NEJM, reconfirms that screening high-risk patients greatly reduces lung cancer deaths. Regulators and physicians should act to ensure access to these lifesaving exams.
Newswise: Latest News
Physicians and Regulators Must Act on NELSON Study published in NEJM to Support Widespread Lung Cancer Screening
July 14, 2020By
